Anixa Biosciences, Inc.
ANIX
$2.79
$0.176.49%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.31% | 17.42% | 12.96% | 10.08% | -4.65% |
| Total Depreciation and Amortization | 26.67% | 12.12% | -2.70% | -10.00% | -37.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.71% | -14.03% | -23.41% | -24.04% | -14.46% |
| Change in Net Operating Assets | -9,000.00% | -170.79% | -71.10% | 156.47% | 100.66% |
| Cash from Operations | 10.78% | 13.25% | 2.21% | 18.29% | -11.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.97% | -50.50% | 13.80% | 80.36% | 1,072.52% |
| Cash from Investing | -82.97% | -50.50% | 13.80% | 80.36% | 1,072.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,721.23% | -27.60% | -30.74% | -44.83% | -91.52% |
| Repurchase of Common Stock | -- | 90.91% | 90.91% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 169.45% | -- | 111.51% | -- |
| Cash from Financing | 1,936.33% | 250.84% | -33.24% | -43.26% | -92.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.32% | 798.18% | -107.58% | 113.68% | 119.78% |